Evidence map›Paper›PMID 26413126›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2015

Bacopa monnieri as an Antioxidant Therapy to Reduce Oxidative Stress in the Aging Brain.

Tamara Simpson, Matthew Pase, Con Stough

Open access · hybridAbstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Efficacy ofJMIR research protocols · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Current issues in molecular biology · 2023
    Review
  12. Article
  13. Journal of clinical and translational research · 2023
    Article
  14. Online Microextraction Coupled with HPLC-ABTS for Rapid Analysis of Antioxidants from the Root ofEvidence-based complementary and alternative medicine : eCAM · 2023
    Article
  15. Article
  16. Dietary supplements in neurological diseases and brain aging.Journal of preventive medicine and hygiene · 2022
    Review
  17. Review
  18. Article
  19. Review
  20. Neuroprotective and Neurorescue Mode of Action ofFrontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Tamara SimpsonCentre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, VIC 3122, Australia.
Matthew PaseCentre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, VIC 3122, Australia ; Department of Neurology, Boston University School of Medicine and Framingham Heart Study, Boston, MA 02118, USA.
Con StoughCentre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, VIC 3122, Australia.
Swinburne University of Technology · AUBoston University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detrimental effect of neuronal cell death due to oxidative stress and mitochondrial dysfunction has been implicated in age-related cognitive decline and neurodegenerative disorders such as Alzheimer's disease. The Indian herb Bacopa monnieri is a dietary antioxidant, with animal and in vitro studies indicating several modes of action that may protect the brain against oxidative damage. In parallel, several studies using the CDRI08 extract have shown that extracts of Bacopa monnieri improve cognitive function in humans. The biological mechanisms of this cognitive enhancement are unknown. In this review we discuss the animal studies and in vivo evidence for Bacopa monnieri as a potential therapeutic antioxidant to reduce oxidative stress and improve cognitive function. We suggest that future studies incorporate neuroimaging particularly magnetic resonance spectroscopy into their randomized controlled trials to better understand whether changes in antioxidant status in vivo cause improvements in cognitive function.

Identifiers

PMID26413126
PMCPMC4564646
OpenAlexW1524119229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.